<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04140955</url>
  </required_header>
  <id_info>
    <org_study_id>1-16-02-211-19</org_study_id>
    <nct_id>NCT04140955</nct_id>
  </id_info>
  <brief_title>Opioid Tapering After Spine Surgery</brief_title>
  <official_title>Opioid Tapering After Spine Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The effect of a tapering plan combined with telephone counselling to assist patients in
      opioid tapering after surgery remains unexplored. A prospective, randomized controlled trial
      investigating the effect of a tapering plan in combination with telephone counselling in
      patients scheduled for spine surgery on a degenerative basis is therefore conducted.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background with aim:

      Preoperative opioid-use is one of the strongest predictors for not tapering off opioids after
      discharge from surgery. In qualitative studies on chronic opioid use, patients call for
      further help and assistance in tapering opioids. The aim of this study is to investigate the
      effect of receiving a tapering plan at discharge and telephone counselling one week after
      discharge on short and long-term opioid-use in preoperative opioid-users who undergo
      scheduled spine surgery.

      Methods:

      One-hundred and ten adult patients scheduled for spine surgery will be included in an
      investigator-initiated, prospective, randomized, controlled trial with two arms: an
      intervention arm (receiving tapering plan at discharge and telephone counselling on opioid
      tapering 5-7 days after discharge) or a control arm (receiving no tapering plan or telephone
      counselling). The study is approved by the Danish Data Protection Agency (1-16-02-211-19) and
      the Central Denmark Region Committees on Health Research Ethics (1-10-72-138-19).

      Hypothesis:

      Our primary hypothesis is that a tapering plan and telephone counselling reduces the
      percentage of patients who exceed their preoperative opioid consumption from 25% to 5% one
      month after discharge.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 22, 2019</start_date>
  <completion_date type="Anticipated">October 22, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 22, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients exceeding their preoperative opioid consumption measured in total Morphine Milligram Equivalents (MME)</measure>
    <time_frame>0-30 days after discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients tapering off to zero measured in total MME</measure>
    <time_frame>0-90 days after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Withdrawal symptoms (yes/no) during opioid tapering</measure>
    <time_frame>0-30 days after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction (very satisfied, satisfied, neither satisfied nor dissatisfied, dissatisfied, very dissatisfied)</measure>
    <time_frame>0-14 days after discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain-related contacts to the primary and/or secondary health care system (yes/no)</measure>
    <time_frame>0-14 days after discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Opioid Withdrawal</condition>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Tapering plan and telephone counselling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive an individually customized tapering plan at discharge and telephone counselling 5-7 days after discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive standard care and treatment, i.e. no tapering plan or telephone counselling.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Tapering plan and telephone counselling</intervention_name>
    <description>Before discharge, a tapering plan is made in collaboration between the patient and one of the investigators. The telephone counselling will include guidance of the patient and/or adjustments of the tapering plan if needed.</description>
    <arm_group_label>Tapering plan and telephone counselling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Daily opioid consumption at least 14 days before surgery

          -  Planned degenerative cervical, thoracic or lumbar spine surgery

        Exclusion Criteria:

          -  Severe physical co-morbidity or inability to participate (dementia, language problems
             or mental illness)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Uhrbrand, MD</last_name>
    <phone>004530615082</phone>
    <email>uhrbrand@clin.au.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lone Nikolajsen, Professor</last_name>
    <phone>004578464317</phone>
    <email>lone.nikolajsen@clin.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <state>Central Denmark Region</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Uhrbrand, MD</last_name>
      <phone>004530615082</phone>
      <email>uhrbrand@clin.au.dk</email>
    </contact>
    <investigator>
      <last_name>Peter Uhrbrand, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mikkel Mylius Rasmussen, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lone Nikolajsen, MD, PhD, DMSc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 22, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Peter Gaarsdal Uhrbrand</investigator_full_name>
    <investigator_title>MD, PhD Student</investigator_title>
  </responsible_party>
  <keyword>Opioid tapering</keyword>
  <keyword>Withdrawal symptoms</keyword>
  <keyword>Spine surgery</keyword>
  <keyword>Patient satisfaction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

